Nucleai Announces Partnership with Protean BioDiagnostics to Enhance Cancer Diagnosis with AI
“TEL AVIV, Israel and TAMPA, Florida, May 7, 2019 /PRNewswire/ -- Nucleai, a precision medicine AI company in the pathology domain, announced today its partnership with Protean BioDiagnostics…”
Read More